Lv5
836 积分 2020-11-02 加入
Rezvilutamide: First Approval
2个月前
已完结
Sevabertinib: First Approval
2个月前
已完结
Comparative effectiveness of mineralocorticoid receptor antagonists in cardiovascular, renal and metabolic disease
3个月前
已关闭
Comparative Effectiveness of Mineralocorticoid Receptor Antagonists in Cardiovascular, Renal and Metabolic Disease
3个月前
已关闭
Finerenone and eGFR Slope across Different Levels of Baseline Albuminuria and eGFR
3个月前
已完结
Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure
3个月前
已关闭
Finerenone in Type 1 Diabetes and Chronic Kidney Disease
3个月前
已完结
Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis
3个月前
已关闭
Clinical Approach to Heart Failure with Preserved Ejection Fraction(HFpEF) in South Asia: An Expert Consensus Statement
3个月前
已完结
皖公网安备34019202002308
